From: Identification of an independent immune-genes prognostic index for renal cell carcinoma
Variables | Total (n = 507) | Training cohort (n = 252) | Validation cohort (n = 255) |
---|---|---|---|
Age (year) | |||
  < 40 | 17 | 9 | 8 |
 40–59 | 225 | 110 | 115 |
 60–79 | 253 | 130 | 123 |
 80+ | 22 | 13 | 9 |
Gender | |||
 FEMALE | 179 | 89 | 90 |
 MALE | 338 | 173 | 165 |
Grade | |||
 G1 | 13 | 6 | 7 |
 G2 | 223 | 125 | 98 |
 G3 | 203 | 91 | 112 |
 G4 | 73 | 37 | 36 |
 GX | 5 | 3 | 2 |
Stage | |||
 I | 257 | 136 | 121 |
 II | 55 | 25 | 30 |
 III | 123 | 63 | 60 |
 IV | 82 | 38 | 44 |
T stage | |||
 T1 | 263 | 137 | 126 |
 T2 | 67 | 31 | 36 |
 T3 | 176 | 87 | 89 |
 T4 | 11 | 7 | 4 |
N stage | |||
 N0 | 236 | 124 | 112 |
 N1 | 15 | 6 | 9 |
 NX | 266 | 132 | 134 |
 M stage |  |  |  |
 M0 | 414 | 217 | 197 |
 M1 | 77 | 35 | 42 |
 MX | 26 | 10 | 16 |